C07D 275/06
With hetero atoms directly attached to the ring sulfur atom
Official title: with hetero atoms directly attached to the ring sulfur atom
C07D275/06 (With hetero atoms directly attached to the ring sulfur atom) appears on 475 US grants and 248 published applications in this corpus.
Search patents in C07D- Granted patents
- 475
- Published applications
- 248
- Assignees
- 234
- Inventors
- 1,090
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 9 | 0 |
| 1978 | 10 | 0 |
| 1979 | 16 | 0 |
| 1980 | 13 | 0 |
| 1981 | 12 | 0 |
| 1982 | 3 | 0 |
| 1983 | 6 | 0 |
| 1984 | 6 | 0 |
| 1985 | 3 | 0 |
| 1986 | 11 | 0 |
| 1987 | 8 | 0 |
| 1988 | 12 | 0 |
| 1989 | 11 | 0 |
| 1990 | 7 | 0 |
| 1991 | 8 | 0 |
| 1992 | 7 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 11 | 0 |
| 1996 | 37 | 0 |
| 1997 | 25 | 0 |
| 1998 | 21 | 0 |
| 1999 | 24 | 0 |
| 2000 | 13 | 0 |
| 2001 | 13 | 2 |
| 2002 | 10 | 8 |
| 2003 | 7 | 7 |
| 2004 | 4 | 12 |
| 2005 | 4 | 11 |
| 2006 | 7 | 15 |
| 2007 | 10 | 11 |
| 2008 | 7 | 9 |
| 2009 | 6 | 16 |
| 2010 | 8 | 11 |
| 2011 | 10 | 11 |
| 2012 | 8 | 12 |
| 2013 | 7 | 5 |
| 2014 | 6 | 8 |
| 2015 | 6 | 15 |
| 2016 | 7 | 11 |
| 2017 | 13 | 8 |
| 2018 | 7 | 15 |
| 2019 | 8 | 5 |
| 2020 | 8 | 10 |
| 2021 | 3 | 9 |
| 2022 | 6 | 10 |
| 2023 | 2 | 5 |
| 2024 | 9 | 9 |
| 2025 | 5 | 6 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors17 Mar 2026US 12,581,252 B2D. E. Shaw Research, LLC
- Nitrosation reagents and methods4 Nov 2025US 12,459,909 B2The Regents of the University of California
- Onium salt, chemically amplified resist composition and patterning process4 Mar 2025US 12,240,804 B2Shin-Etsu Chemical Co., Ltd.
- Substituted isoindolines as PI3K-alpha inhibitors4 Feb 2025US 12,219,327 B2D. E. Shaw Research, LLC
- Bleach Catalyst and Composition Comprising Said Catalyst24 Sep 2026US 2026/0286254 A1Reckitt Benckiser Vanish B.V.
- Bleach Catalyst With Improved Performance, Granule Comprising The Bleach Catalyst, And Composition Comprising Said Catalyst Or Said Granule17 Sep 2026US 2026/0275249 A1Reckitt Benckiser Vanish B.V.
- Crystalline forms and formulations of a kras inhibitor3 Sep 2026US 2026/0258055 A1Eli Lilly and Company
- Pi3k-alpha inhibitors and methods of use thereof16 Jul 2026US 2026/0205746 A1D. E. Shaw Research, LLC
- Electrophilic reactive linkers for labeling of polypeptides and methods of use thereof25 Jun 2026US 2026/0174880 A1President and Fellows of Harvard College
Most cited
By later US patents
- 4-Hydroxy-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxides and salts thereof142US 4,233,299 ABoehringer Ingelheim GmbH · 1980
- Substituted phenethylsulfones and method of reducing TNF.alpha. levels136US 6,020,358 ACelgene Corporation · 2000
- Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics115US 5,364,866 AHoechst-Roussel Pharmaceuticals Inc. · 1994
- Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof90US 5,236,917 ASterling Winthrop Inc. · 1993
- Imide derivatives, and their production and use84US 5,532,372 ASumitomo Pharmaceuticals Company, Limited · 1996